Q1 2022
Released May 13, 2022, during market hours
10-Q filed May 13, 2022, 43 days after period end · 0001493152-22-013346
Q1 2022 · 10-Q
Revenue$47.53M$47.53M +211.3% vs Q1 2021+5.3% vs Q4 2021
Net Income$12.49M$12.49M +1,082.0% vs Q1 2021+18.0% vs Q4 2021
EPS Diluted$0.68$0.68 +1,033.3% vs Q1 2021no prior Q4 2021 on file
Gross Profit$28,677,000+221.2%
Operating Income$16,146,000+1,222.4%
Operating Cash Flow$20,287,000N/M
Free Cash Flowderived$19,192,000N/M
Margins · derived
Gross margin60.3%+1.9 pt vs Q1 2021
Operating margin34.0%+26.0 pt vs Q1 2021
Net margin26.3%+19.4 pt vs Q1 2021
What the release said
The release
Same quarter
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $47.53M | $15.27M | $1.89M | $2.32M |
| Net Income | $12.49M | $1.06M | -$809.00K | -$1.01M |
| EPS Diluted | $0.68 | $0.06 | -$0.07 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR